Page 2 - Initial Phase News Today

Maha Energy AB (publ) (“Maha” or the ”Company”) announces that it has been granted by the Ministry of Energy and Minerals of the Sultanate of Oman (“MEM”)...

Ever wondered how long the journey is from a politician's first announcement of candidacy to the moment their fate is sealed on election day? It's a marathon not a sprint, fraught with strategy, messaging, and countless handshakes. But exactly how long does this process take on average in American politics?The average length of a political

Initial Phase 1b clinical data for ORIC-114 in EGFR/HER2-mutated cancers to be presented at the ESMO Congress being held October 20-24, 2023Initia...

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

During the extended Initial Phase, Maha intends to implement activities necessary to support any decision regarding Block 70’s declaration of commerciality, such as preparing a detailed plan for enhanced oil recovery, such as steam, waterflooding or other production enhancement methods.

Maha Energy AB (publ) (“Maha” or the “Company”) announces the results of the initial short-term production test on Block 70 in the Sultanate of Oman (“Initial Phase”). All 8 (eight) production wells drilled in the 2022/2023 drilling program were tested for short term and 5 (five) produced oil to surface at an initial estimated average rate of 300 barrels of oil per day per well, while 3 (three) had to be suspended after producing water and gas but before...

PreHevbrio global net revenue increased 90% quarter-over-quarter from Q4 2022 to Q1 2023 as access to PreHevbrio continues to broaden – now available at several U.S. retail pharmacy chains... | May 15, 2023

The frustrated police officers appear to make no effort to stop the bikers dangerous antics in Leeds as he repeatedly gets into the kneeling position on the saddle and vanishes into the traffic.

- Interim results from Phase 2 innovaTV 207 trial of tisotumab vedotin in head and neck cancer to be presented -- Initial Phase 1 dose-escalation data for SEA-TGT monotherapy in advanced malignancies to be disclosed -- Preclinical data and discovery research underscore Seagen’s mission to innovate through next-gener...

01.03.2023 - - Achieved $31.3 Million in Net Revenue from Sales of COSELA (trilaciclib) for Full Year 2022, Representing 182% Growth Over 2021; Provided 2023 Net COSELA Revenue Guidance of $50 to $60 Million - - Announced Top Line Results from Pivotal Phase 3 ...